These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22133295)

  • 1. Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro.
    Keller AC; Ma J; Kavalier A; He K; Brillantes AM; Kennelly EJ
    Phytomedicine; 2011 Dec; 19(1):32-7. PubMed ID: 22133295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cucurbitane-type triterpenoids from Momordica charantia.
    Ma J; Whittaker P; Keller AC; Mazzola EP; Pawar RS; White KD; Callahan JH; Kennelly EJ; Krynitsky AJ; Rader JI
    Planta Med; 2010 Oct; 76(15):1758-61. PubMed ID: 20379957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycaemic activity of saponin fraction extracted from Momordica charantia in PEG/salt aqueous two-phase systems.
    Han C; Hui Q; Wang Y
    Nat Prod Res; 2008; 22(13):1112-9. PubMed ID: 18855210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saponins of Momordica charantia increase insulin secretion in INS-1 pancreatic β-cells via the PI3K/Akt/FoxO1 signaling pathway.
    Liu Y; Mu S; Chen W; Liu S; Cong Y; Liu J; Jia N
    Endocrinol Diabetes Nutr (Engl Ed); 2021 May; 68(5):329-337. PubMed ID: 34556263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport in Caco-2 cell monolayers of antidiabetic cucurbitane triterpenoids from Momordica charantia fruits.
    Wu SB; Yue GG; To MH; Keller AC; Lau CB; Kennelly EJ
    Planta Med; 2014 Jul; 80(11):907-11. PubMed ID: 25116119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities.
    Yibchok-anun S; Adisakwattana S; Yao CY; Sangvanich P; Roengsumran S; Hsu WH
    Biol Pharm Bull; 2006 Jun; 29(6):1126-31. PubMed ID: 16755004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction.
    Oishi Y; Sakamoto T; Udagawa H; Taniguchi H; Kobayashi-Hattori K; Ozawa Y; Takita T
    Biosci Biotechnol Biochem; 2007 Mar; 71(3):735-40. PubMed ID: 17341830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.
    Sun K; Ding M; Fu C; Li P; Li T; Fang L; Xu J; Zhao Y
    J Ethnopharmacol; 2023 Apr; 306():116154. PubMed ID: 36634725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic and Anti-Inflammatory Triterpenoids in the Vines and Leaves of
    Chou MC; Lee YJ; Wang YT; Cheng SY; Cheng HL
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cucurbitane triterpenoids from Momordica charantia.
    Li QY; Chen HB; Liu ZM; Wang B; Zhao YY
    Magn Reson Chem; 2007 Jun; 45(6):451-6. PubMed ID: 17431862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Momordica charantia constituents and antidiabetic screening of the isolated major compounds.
    Harinantenaina L; Tanaka M; Takaoka S; Oda M; Mogami O; Uchida M; Asakawa Y
    Chem Pharm Bull (Tokyo); 2006 Jul; 54(7):1017-21. PubMed ID: 16819222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cucurbitane Triterpenoids from the Fruits of Momordica Charantia Improve Insulin Sensitivity and Glucose Homeostasis in Streptozotocin-Induced Diabetic Mice.
    Han JH; Tuan NQ; Park MH; Quan KT; Oh J; Heo KS; Na M; Myung CS
    Mol Nutr Food Res; 2018 Apr; 62(7):e1700769. PubMed ID: 29405623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cucurbitane-type triterpenoids from the fruit of Momordica charantia.
    Kimura Y; Akihisa T; Yuasa N; Ukiya M; Suzuki T; Toriyama M; Motohashi S; Tokuda H
    J Nat Prod; 2005 May; 68(5):807-9. PubMed ID: 15921438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cucurbitane-type triterpenoids from Momordica charantia.
    Chang CI; Chen CR; Liao YW; Cheng HL; Chen YC; Chou CH
    J Nat Prod; 2006 Aug; 69(8):1168-71. PubMed ID: 16933869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects and associated mechanisms of
    Wang S; Liu Q; Zeng T; Zhan J; Zhao H; Ho CT; Xiao Y; Li S
    Food Funct; 2022 Nov; 13(23):11986-11998. PubMed ID: 36350105
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo hypoglycemic effect of methanolic fruit extract of Momordica charantia L.
    Nkambo W; Anyama NG; Onegi B
    Afr Health Sci; 2013 Dec; 13(4):933-9. PubMed ID: 24940315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative and hypoglycemic cucurbitane-type glycosides from the fruits of Momordica charantia.
    Hsiao PC; Liaw CC; Hwang SY; Cheng HL; Zhang LJ; Shen CC; Hsu FL; Kuo YH
    J Agric Food Chem; 2013 Mar; 61(12):2979-86. PubMed ID: 23432055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Momordica charantia reverses type II diabetes in rat.
    Malekshahi H; Bahrami G; Miraghaee S; Ahmadi SA; Sajadimajd S; Hatami R; Mohammadi B; Keshavarzi S
    J Food Biochem; 2019 Nov; 43(11):e13021. PubMed ID: 31441956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antidiabetic activity of Taraxacum officinale (L.) Weber ex F.H.Wigg and Momordica charantia L. polyherbal combination.
    Perumal N; Nallappan M; Shohaimi S; Kassim NK; Tee TT; Cheah YH
    Biomed Pharmacother; 2022 Jan; 145():112401. PubMed ID: 34785415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
    Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ
    Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.